Real-life switching strategies with second-generation antipsychotics

J Clin Psychiatry. 2006 Jan;67(1):160-1. doi: 10.4088/jcp.v67n0122.
No abstract available

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use
  • Cohort Studies
  • Dibenzothiazepines / administration & dosage
  • Dibenzothiazepines / adverse effects
  • Dibenzothiazepines / therapeutic use
  • Drug Administration Schedule
  • Drug Resistance
  • Humans
  • Mental Disorders / drug therapy*
  • Olanzapine
  • Piperazines / administration & dosage
  • Piperazines / adverse effects
  • Piperazines / therapeutic use
  • Psychotic Disorders / drug therapy
  • Quetiapine Fumarate
  • Randomized Controlled Trials as Topic / methods
  • Selection Bias
  • Thiazoles / administration & dosage
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Piperazines
  • Thiazoles
  • Benzodiazepines
  • Quetiapine Fumarate
  • ziprasidone
  • Olanzapine